| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 01/14/2004 | CN1134411C Bicyclic amino derivatives and PGD2 antagonist containing same |
| 01/14/2004 | CN1134410C Amine derivative, process for producing same, and use thereof as antiarrhythmic medicine |
| 01/14/2004 | CN1134264C Antithrombotic agents |
| 01/13/2004 | US6677487 Combining a tertiary amide with a pentavalent phosphorous halide in a solvent to form an alpha - haloiminium salt and converting the alpha -haloiminium salt to the alpha -haloenamine with a base |
| 01/13/2004 | US6677382 Halogenated oxyamines, used as enzyme inhibitors for prophylaxis of atherosclerosis and cardiovascular disorders, and as antilipemic agents |
| 01/13/2004 | US6677380 Antilipemic agents such as 3(3-(4-chloro-3-ethyl-phenoxy)-phenyl)((3-(1,1,2,2 -tetrafluoroethoxy)phenyl)methyl))amino)-1,1,1-trifluro-2-propanthiol, used for prophlaxis of cardiovascular disorders and atherosclerosis |
| 01/13/2004 | US6677379 Such as 3-((3-(3-trifluoromethoxyphenoxy)phenyl)((3-(1,1,2,2-tetrafluoroethoxy) -phenyl)methyl) amino)-1,1,1-trifluoro-2-propanol for treatment of coronary artery disease |
| 01/13/2004 | US6677378 Monoamine reuptake inhibitors for treatment of CNS disorders |
| 01/13/2004 | US6677375 Substituted N,N-bis-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 01/13/2004 | US6677360 Biphenyl and biphenyl-analogous compounds as integrin antagonists |
| 01/13/2004 | US6677353 Substituted N-phenyl-N-heteroaralkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 01/08/2004 | WO2004002977A1 Inhibitors of hcv ns5b polymerase |
| 01/08/2004 | WO2004002944A1 Inhibitors of hcv ns5b polymerase |
| 01/08/2004 | WO2004002943A1 4-(3,3-dihalo-allyloxy)phenoxy alkyl derivatives |
| 01/08/2004 | WO2004002940A1 Inhibitors of hcv ns5b polymerase |
| 01/08/2004 | WO2004002491A1 Morpholine and tetrahydropyran drivatives and their use as cathepsin inhibitors |
| 01/08/2004 | WO2003030899A3 Use of 2-oxo-1-pyrrolidine derivatives for the treatment of dyskinesia and movement disorders |
| 01/08/2004 | US20040006236 Diaminopropionic acid derivatives |
| 01/08/2004 | US20040006233 Synthetic multimerizing agents |
| 01/08/2004 | US20040006231 Process for the synthesis of 1,3-diols |
| 01/08/2004 | US20040006166 Compatible with a wide variety of adhesive formulations and which provide substantial adhesion enhancement relative to base formulations to which they are added |
| 01/08/2004 | US20040006107 For prophylaxis of asthma and other allergic diseases |
| 01/08/2004 | US20040006096 Substituted alkanohydroxamic acids and method of reducing TNFalpha levels |
| 01/08/2004 | US20040006078 For therapy of autoimmune diseases, asthma, osteoporosis, atherosclerosis, Alzheimer's disease |
| 01/08/2004 | US20040006049 For therapy of prostatitis, benign prostate hyperplasia or prostate cancer |
| 01/08/2004 | US20040006023 Intravenous administration of a alpha -halogen- acryloyl distamycin derivative for therapy of tumors |
| 01/08/2004 | CA2491156A1 Inhibitors of hcv ns5b polymerase |
| 01/08/2004 | CA2490950A1 Inhibitors of hcv ns5b polymerase |
| 01/08/2004 | CA2489433A1 Inhibitors of hcv ns5b polymerase |
| 01/08/2004 | CA2488525A1 Morpholine and tetrahydropyran derivatives and their use as cathepsin inhibitors |
| 01/07/2004 | EP1378230A1 Para-phenylenediamine derivatives comprising a pyrrolidinyl group substituted by a cyclic radical and their use in colouring keratinic fibres |
| 01/07/2004 | EP1377543A1 Oxalic acid derivatives |
| 01/07/2004 | EP1377295A2 Carboxamide derivatives as therapeutic agents |
| 01/07/2004 | EP1377278A1 Treatment of type 2 diabetes with inhibitors of dipeptidyl peptidase iv |
| 01/07/2004 | EP1056733B1 Histamine h3 receptor ligands |
| 01/07/2004 | CN1466572A 吡咯衍生物 Azole derivatives |
| 01/07/2004 | CN1466571A Method for producing delta 1-pyrrolines |
| 01/06/2004 | US6673920 Method for the production of N-alkenyl-amides |
| 01/06/2004 | US6673829 Treatment of diseases of the central nervous system, the peripheral nervous system, the cardiovascular system, the pulmonary system, the gastrointestinal system and the endocrinological system. |
| 01/06/2004 | US6673817 Anticoagulants |
| 01/06/2004 | US6673803 Quinazoline derivatives and pharmaceutical compositions containing them |
| 01/06/2004 | US6673772 Dipeptide compounds and their use as antiviral agents |
| 01/06/2004 | US6673257 Blends employing at least two organic compounds having known melt temperatures, exhibit improved thermal properties and performance characteristics |
| 01/02/2004 | EP1375482A1 Benzamidine derivative |
| 01/02/2004 | EP1375481A1 Method of purifying n-(2-hydroxyethyl)-2-pyrrolidone |
| 01/02/2004 | EP1375480A1 Para-phenylene-diamine derivatives comprising a silyl substituted pyrrolidine group and their use for the colouring of keratinic fibres |
| 01/02/2004 | EP1375479A1 Pyrrolidine derivative and process for producing the same |
| 01/02/2004 | EP1375465A1 Cyclooctanone derivative and cyclodecanone derivative, and use thereof |
| 01/02/2004 | EP1373494A2 Succinimide and maleimide derivatives and their use as topoisomerase ii catalytic inhibitors |
| 01/02/2004 | EP1373208A1 A process for the synthesis of an aliphatic cyclic amine |
| 01/02/2004 | EP1373202A1 Preparation of non-crystalline atorvastatin calcium |
| 01/02/2004 | EP1373191A1 Acylated indanyl amines and their use as pharmaceuticals |
| 01/02/2004 | EP1372692A2 Asymmetric synthesis of (s, s, r)-(-)-actinonin and its analogs and uses therefor |
| 01/02/2004 | EP1372655A2 Cathepsin cysteine protease inhibitors |
| 01/02/2004 | EP1140819B1 Alfa-sulfenimino acid derivatives |
| 01/02/2004 | EP1027339B1 Method and reagents for n-alkylating ureides |
| 01/01/2004 | US20040002609 Antidiabetic agents; metabolism diseases; hypotensive agents; cardiovascular disorders |
| 01/01/2004 | US20040002542 Succinoylamino hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitors |
| 01/01/2004 | US20040002539 Enzyme inhibitors; anticoagulants; blood collecting device |
| 01/01/2004 | US20040002533 Culture product of Streptomyces; lanosterol synthase inhibitor; anticholesterol agents, fungicides |
| 01/01/2004 | US20040002515 Antihistamines; antiallergens; antiinflammatory agents; autoimmune diseases; rheumatic diseases |
| 01/01/2004 | US20040002491 Melatonergic receptors |
| 01/01/2004 | US20040002490 Melatonergic receptors |
| 01/01/2004 | US20040002485 Enzyme inhibitors; viricides |
| 12/31/2003 | WO2004000828A1 New compounds useful for the treatment of obesity, type ii diabetes and cns disorders |
| 12/31/2003 | WO2004000806A1 Amides of cyclic amino acids used as pde 4 inhibitors |
| 12/31/2003 | WO2004000802A2 Scaffolded maleimide clusters for multivalent peptide assembly |
| 12/31/2003 | WO2004000797A1 Alpha-sulfonylamino-acetonitriles |
| 12/31/2003 | WO2003073999A3 Pini-modulating compounds and methods of use thereof |
| 12/31/2003 | WO2003069303A3 Antimalarial and antiproliferative pharmacophore models, novel tryptanthrin compounds having increased solubility, and methods of making and using thereof |
| 12/31/2003 | WO2003063576A3 Arylsulfonamidobenzylic compounds |
| 12/31/2003 | WO2003035058A3 Polymaleide compounds and their medical use |
| 12/31/2003 | CN1464881A New dipeptidyl peptidase iv inhibitors and their uses as anti-cancer agents |
| 12/31/2003 | CN1463967A Opioid receptor containing 3-pyrroline, process for preparing the same and use thereof |
| 12/31/2003 | CN1132836C 各种片螺素化合物和类似物的合成及中间体 And various synthetic intermediates lamellarin compounds and the like |
| 12/31/2003 | CA2490124A1 Scaffolded maleimide clusters for multivalent peptide assembly |
| 12/31/2003 | CA2486989A1 New compounds useful for the treatment of obesity, type ii diabetes and cns disorders |
| 12/30/2003 | US6670483 Catalytically hydrogenating n-methyl-succinimide to form n-methylpyrrolidone |
| 12/30/2003 | US6670479 Amination process |
| 12/30/2003 | US6670386 For therapy of nuclear hormone receptor-associated conditions, such as age related diseases, for example sarcopenia |
| 12/30/2003 | US6670358 Substituted thioacetamides |
| 12/30/2003 | US6670357 Antiinflammatory agents |
| 12/30/2003 | CA2198637C Preparation of quaternized glycine nitriles |
| 12/30/2003 | CA2052884C Angiotensin 11 antagonists in the treatment of hyperuricemia |
| 12/30/2003 | CA2051399C Therapeutically useful 2-aminotetralin derivatives |
| 12/25/2003 | US20030236438 Enantioselective 1,4-addition of aromatic nucleophiles to alpha,beta-unsaturated aldehydes using chiral organic catalysts |
| 12/25/2003 | US20030236415 Etherifying mucochloric or mucobromic acid with an alcohol, alkylation, hydrogenation, dehydrochlorination or dehydrobromination, decyclization by reductive amination and carboxylation; 3-Aminomethyl-5-methyl-hexanoic acid |
| 12/25/2003 | US20030236403 Certain substituted 1-aryl-3-piperazine-1'-yl propanones |
| 12/25/2003 | US20030236401 Asymmetric synthesis of amino-pyrrolidinones |
| 12/25/2003 | US20030236254 Novel heterocyclic compounds having hypolipidemic, hypocholesteremic activities process for their preparation and pharmaceutical compositions containing them and their use in medicine |
| 12/25/2003 | US20030236250 Antidepressants, anxiolytic agents, analgesics, antiinflammatory agents, reduce concentration of tachykinins |
| 12/25/2003 | US20030236248 Kappa agonist compounds and pharmaceutical formulations thereof |
| 12/25/2003 | US20030236198 For treatment of infections by drug resistant bacteria |
| 12/24/2003 | WO2003106456A2 New compounds |
| 12/24/2003 | WO2003106445A1 Compounds and methods for controlling bacterial virulence |
| 12/24/2003 | WO2003106417A1 Mitotic kinesin inhibitors |
| 12/24/2003 | WO2003106405A1 Aspartyl protease inhibitors |
| 12/24/2003 | WO2003106390A1 Polymerisation inhibitor |
| 12/24/2003 | WO2003105855A1 Mitotic kinesin inhibitors |
| 12/24/2003 | WO2003105756A2 Stereoselective synthesis of 1,2-disubstituted cycloalkyls |